Article
Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.
JCI insight - 22 Sept 2021
Herborg Freja, Jensen Kathrine L, Tolstoy Sasha, Arends Natascha V, Posselt Leonie P, Shekar Aparna, Aguilar Jenny I, Lund Viktor K, Erreger Kevin, Rickhag Mattias, Lycas Matthew D, Lonsdale Markus N, Rahbek-Clemmensen Troels, Sørensen Andreas T, Newman Amy H, Løkkegaard Annemette, Kjærulff Ole, Werge Thomas, Møller Lisbeth B, Matthies Heinrich Jg, Galli Aurelio, Hjermind Lena E, Gether Ulrik
Abstract excerpt
Dysfunctional dopaminergic neurotransmission is central to movement disorders and mental diseases. The dopamine transporter (DAT) regulates extracellular dopamine levels, but the genetic and mechanistic link between DAT function and dopamine-related pathologies is not clear. Particularly, the pathophysiological significance of monoallelic missense mutations in DAT is unknown. Here, we use clinical information,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
